Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity-论文-万方医学网

Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity

导出原文传递

翻译打印收藏纠错

作者： Scheurer, J. ^[1] ; Reisser, T. ^[2] ; Leithaeuser, F. ^[3] ; Messmann, J. J. ; Holzmann, K. ; Debatin, K. M. ; Strauss, G.

作者单位： Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany ^[1] Univ Ulm, Inst Pathol, Ulm, Germany ^[2] Univ Ulm, Genom Core Facil, Ulm, Germany ^[3]

关键词 GVHD allogeneic bone marrow transplantation GVT effect MDSCs rapamycin

发布时间 2021-03-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity

相似文献

相关期刊

检索历史清除